| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 118 | 744 | 1.243 | 2.119 | 2.973 | 4.300 | 2.471 | 0 | 0 |
| Total Income - EUR | - | 5.367 | 2.895 | 12.151 | 8.182 | 10.751 | 10.325 | 13.403 | 2.002 | 23 |
| Total Expenses - EUR | - | 381 | 259 | 98 | 390 | 139 | 134 | 397 | 165 | 82 |
| Gross Profit/Loss - EUR | - | 4.986 | 2.637 | 12.053 | 7.792 | 10.612 | 10.191 | 13.006 | 1.837 | -59 |
| Net Profit/Loss - EUR | - | 4.982 | 2.614 | 12.016 | 7.728 | 10.532 | 10.062 | 12.893 | 1.837 | -59 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ferma Angus Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 11.291 | 13.381 | 25.126 | 32.431 | 42.277 | 51.401 | 13.192 | 3.588 | 3.532 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 32 | 6 | 2.125 | 2.979 | 4.306 | 11.980 | 144 | 144 |
| Cash | - | 11.291 | 13.349 | 25.120 | 30.306 | 39.298 | 47.095 | 1.212 | 3.444 | 3.389 |
| Shareholders Funds | - | 5.013 | 7.543 | 19.420 | 26.772 | 36.797 | 46.042 | 12.934 | 3.386 | 3.307 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 6.278 | 5.838 | 5.706 | 5.659 | 5.480 | 5.359 | 258 | 202 | 225 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "150 - 150" | |||||||||
| CAEN Financial Year |
150
|
|||||||||
Comments - Ferma Angus Bio Srl